Listen to The Lancet Neurology

Michael Irwin (University of California, Los Angeles, USA) discusses a Review concerning potential links of sleep disturbance and possible increased risk of Alzheimer's disease dementia.

Lindsay Wallace and Kenneth Rockwood join  The Lancet Neurology to talk about their work on the association between frailty and the onset of Alzheimer's disease.

In the latest podcast from The Lancet Neurology , Jan Scheitz discusses the development of stroke–heart syndrome.

Mark Cook and Phillippa Karoly join  The Lancet Neurology to discuss their retrospective study of cyclical patterns in epileptic seizures.

Bruce Trapp and Daniel Ontaneda discuss their retrospective study investigating cortical neuronal loss and cerebral white-matter demyelination in mulitple sclerosis.

Josep Dalmau joins The Lancet Neurology to discuss recognition and outcomes of autoimmune encephalitis after herpes simplex encephalitis.

David Eidelberg and Katharina Schindelbeck join  The Lancet Neurology to explain their new review of the applications of network imaging biomarkers in Parkinson's disease.

Eugene Major and David Clifford join  The Lancet Neurology to discuss their review of pathogenesis and treatments for progressive multifocal leukoencephalopathy.

Torbjörn Tomson discusses the issue of antiepileptic drugs during pregnancy and the risk of major congenital malformations.

Christian Elger discusses the diagnostic challenges in epilepsy with the detection and reporting of seizures.

Jeffrey Cohen joins us to talk about the process of updating and revising the McDonald criteria for diagnosis of MS.

Jose Bras discusses his study of the genetic architecture of dementia with Lewy bodies.

Andrew Maas and David Menon, lead authors, discuss  The Lancet Neurology Commission on traumatic brain injury and outline the worldwide burden.

Keith Josephs talks about considering TDP-43 as a potential factor related to increased rates of hippocampal atrophy in patients with Alzheimer's disease.

Cathy Stinear discusses her review of biomarkers that might predict motor recovery after stroke.

Lesley Jones and Sarah Tabrizi talk about their work on the identification of genetic markers associated with the progression of Huntington's disease.

Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.

Adam Boxer offers an overview of the latest on diagnosis and treatment for progressive supranuclear palsy.

Eva Feldman discusses the neurological consequences of obesity.

Marc Diamond discusses his Personal View on the prion model for progression and diversity of neurodegenerative diseases.

Randall Bateman and Nick Fox discuss what they've learned from their papers on Alzheimer's disease.

Professor Thomas Similowski discusses his surprising study on the effectiveness of non-invasive ventilation for patients with amyotrophic lateral sclerosis.

Dr. Kiran Maski discusses insomnia, parasomnia, and narcolepsy in children.

Dr. Gustavo Saposnik discusses the efficacy of non-immersive virtual reality exercise in the treatment of stroke.

Professor Valery Feigin discusses an Article on the global burden of stroke and risk factors from 1990–2013.